← Open Payments lookup

THELMA ARARACAP: Open Payments

NPI 1437471059 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,747 in 163 payments from 21 companies in 2025. Trend: 2023 $2,606 · 2024 $3,223 · 2025 $3,747

Food & beverage: $3,747
CompanyPaymentsAmount
ABBVIE INC.52$1,161
Janssen Biotech, Inc.26$636
PFIZER INC.14$318
Gilead Sciences, Inc.8$234
Aimmune Therapeutics, Inc.12$178
GENZYME CORPORATION12$165
Takeda Pharmaceuticals U.S.A., Inc.7$162
Galderma Laboratories, L.P.1$142
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$109
Enterra Medical, Inc.1$109

Products named: TREMFYA, CREON, RINVOQ, LINZESS, VELSIPITY, ZENPEP, DUPIXENT, NEMLUVIO.

Industry payments across NV — which companies pay providers there.